Stay updated with breaking news from Vascular Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sean Salmon, Executive Vice President & President Cardiovascular at Medtronic PLC (NYSE:MDT), executed a sale of 30,695 shares in the company on February 21, 2024, according to a recent SEC Filing.
PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood
Q3 2023 Product sales grew 20% to $7.8M versus $6.5M in Q3 2022. Q3 2023 Total revenue was approximately $8.8M. The pivotal STAR-T trial remains blinded with database lock nearing and initial data analysis completion expected before year-end.PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorptio
ZANESVILLE – Dilpreet Singh, M.D., has joined the Genesis Heart & Vascular Group, specializing in interventional cardiology. He earned his doctor of medicine at American University of the Caribbean School
News items for the local area